FOLH1 and prostate cancer: Recent success in using 68Ga/68Ge generator generator-based 68Ga-DOTATATE and 68Ga-PSMA-11 for routine diagnosis of neuroendocrine and prostate cancer, respectively, would likely to increase the acceptance of 68Ga tracers for routine clinical application.